SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-046253
Filing Date
2017-12-14
Accepted
2017-12-14 16:57:37
Documents
1
Period of Report
2017-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 8398
  Complete submission text file 0001140361-17-046253.txt   9753
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 PROFESSIONAL DRIVE SUITE 400 GAITHERSBURG MD 20879
Business Address
Abdun-Nabi Daniel (Reporting) CIK: 0001380187 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 171256738